Skip to main content

Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • The swell of novel coronavirus appears not abating. In just a few months from the outbreak, it has reached around 210 countries, took lives of more than one lakh people. The numbers are climbing. In an effort to place a hurdle before the runaway train, scientists across the globe are racing to develop a drug that can cure or a vaccine that stop its spread.

  • Researchers at Rajiv Gandhi Centre for Biotechnology (RGCB), Thiruvananthapuram are in the final stages of developing a kit that promises to help detect SARS CoVID-19 infection as early as four days post-infection of the virus.

  • The Food and Drug Administration (FDA or the Agency) plays a critical role in protecting the United States from threats such as emerging infectious diseases, including the Coronavirus Disease 2019 (COVID-19) pandemic. FDA is committed to providing timely guidance to support response efforts to this pandemic.

  • Indian scientists are working day and night to find solutions against the threat of Covid-19. Scientists from Central Salt and Marine Chemical Research Institute (CSMCRI), located in Bhavnagar, Gujarat, have developed a unique face-mask, which can destroy the virus.

  • Loss of smell and taste has been anecdotally linked to COVID-19 infections. In a study published April 12, 2020 in the journal International Forum of Allergy & Rhinology , researchers at UC San Diego Health report the first empirical findings that strongly associate sensory loss with COVID-19, the respiratory disease caused by the novel coronavirus.

  • In a recent study published in the Proceedings of the National Academy of Sciences (PNAS), University of California San Diego researchers moved one step closer to the ability to make heparin in cultured cells. Heparin is a potent anti-coagulant and the most prescribed drug in hospitals, yet cell-culture-based production of heparin is currently not possible.

Subscribe to Pharma News